0001493152-21-017685.txt : 20210723
0001493152-21-017685.hdr.sgml : 20210723
20210723174237
ACCESSION NUMBER: 0001493152-21-017685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210723
FILED AS OF DATE: 20210723
DATE AS OF CHANGE: 20210723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOLL ANDREW R.
CENTRAL INDEX KEY: 0001542150
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 211111775
MAIL ADDRESS:
STREET 1: 437 S HWY 101
STREET 2: STE 209
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER NAME:
FORMER CONFORMED NAME: Boll Andrew
DATE OF NAME CHANGE: 20120210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW HEALTH, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
4
1
ownership.xml
X0306
4
2021-07-23
0
0001360214
HARROW HEALTH, INC.
HROW
0001542150
BOLL ANDREW R.
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
Chief Financial Officer
Restricted Stock Unit
2021-07-23
4
A
0
346500
0
A
2026-07-23
Common Stock
346500
346500
D
Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.
/s/ Andrew R. Boll
2021-07-23